| Westminster Village - West Lafayette | |
| 2741 N Salisbury St, West Lafayette, Indiana 47906 | |
| (765) 463-7546 | |
| Name | Westminster Village - West Lafayette |
|---|---|
| Location | 2741 N Salisbury St, West Lafayette, Indiana |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 72 |
| Occupancy Rate | 77.64% |
| Medicare ID (CCN) | 155177 |
| Legal Business Name | Westminster Village West Lafayette, Inc |
| Ownership Type | Non Profit - Corporation |
| NPI Number | 1497740633 |
| Organization Name | WESTMINSTER VILLAGE WEST LAFAYETTE, INC |
| Address | 2741 N Salisbury St, West Lafayette, IN 47906 |
| Phone Number | 765-463-7546 |
News Archive
A new study published on the preprint server medRxiv in August 2020 discusses the root causes underlying the emergence of such infectious diseases following their crossover of the line separating animal viruses from human. This initial event is of enormous significance.
According to newly published research, a specialized psychotherapy has been linked to changes in activation patterns in certain areas of the brain in patients with borderline personality disorder (BPD), suggesting its impact may go deeper than symptom change.
Millions of people have a genetic variant linked to increased risk of ischemic stroke, reports an international research team including scientists at The University of Texas Health Science Center at Houston in a study published online by The New England Journal of Medicine on April 15.
Today leading New Zealand biotechnology company Therapy Cell Ltd announced it was moving to the United States through its merger with Therapy Cells Inc (formerly DIII OTC Market). This exciting Bio Tech/Med tech Company holds the exclusive technology that allows adult cells from a specific tissue (e.g. Achilles tendon) to grow again from an individual to enact repair and regeneration of that tissue.
Schizophrenia is a severe and complex psychiatric illness that affects about 1% of the population. Diagnosis currently relies on subjective clinical interviews and the assessment of ambiguous symptoms, which frequently leads to delayed diagnosis and treatment. As such, biomarkers that would indicate schizophrenia risk or onset would be extremely useful.
› Verified 2 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
A new study published on the preprint server medRxiv in August 2020 discusses the root causes underlying the emergence of such infectious diseases following their crossover of the line separating animal viruses from human. This initial event is of enormous significance.
According to newly published research, a specialized psychotherapy has been linked to changes in activation patterns in certain areas of the brain in patients with borderline personality disorder (BPD), suggesting its impact may go deeper than symptom change.
Millions of people have a genetic variant linked to increased risk of ischemic stroke, reports an international research team including scientists at The University of Texas Health Science Center at Houston in a study published online by The New England Journal of Medicine on April 15.
Today leading New Zealand biotechnology company Therapy Cell Ltd announced it was moving to the United States through its merger with Therapy Cells Inc (formerly DIII OTC Market). This exciting Bio Tech/Med tech Company holds the exclusive technology that allows adult cells from a specific tissue (e.g. Achilles tendon) to grow again from an individual to enact repair and regeneration of that tissue.
Schizophrenia is a severe and complex psychiatric illness that affects about 1% of the population. Diagnosis currently relies on subjective clinical interviews and the assessment of ambiguous symptoms, which frequently leads to delayed diagnosis and treatment. As such, biomarkers that would indicate schizophrenia risk or onset would be extremely useful.
› Verified 2 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 13.33 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 1.06 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 55.43 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 3.15 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 2.69 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 2.49 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 10.68 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 87.38 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 6.34 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 63.47 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 20.9 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 14.81 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 9.4 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 94.17 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 94.05 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 69.72 | 82.93 |
News Archive
A new study published on the preprint server medRxiv in August 2020 discusses the root causes underlying the emergence of such infectious diseases following their crossover of the line separating animal viruses from human. This initial event is of enormous significance.
According to newly published research, a specialized psychotherapy has been linked to changes in activation patterns in certain areas of the brain in patients with borderline personality disorder (BPD), suggesting its impact may go deeper than symptom change.
Millions of people have a genetic variant linked to increased risk of ischemic stroke, reports an international research team including scientists at The University of Texas Health Science Center at Houston in a study published online by The New England Journal of Medicine on April 15.
Today leading New Zealand biotechnology company Therapy Cell Ltd announced it was moving to the United States through its merger with Therapy Cells Inc (formerly DIII OTC Market). This exciting Bio Tech/Med tech Company holds the exclusive technology that allows adult cells from a specific tissue (e.g. Achilles tendon) to grow again from an individual to enact repair and regeneration of that tissue.
Schizophrenia is a severe and complex psychiatric illness that affects about 1% of the population. Diagnosis currently relies on subjective clinical interviews and the assessment of ambiguous symptoms, which frequently leads to delayed diagnosis and treatment. As such, biomarkers that would indicate schizophrenia risk or onset would be extremely useful.
› Verified 2 days ago
Westminster Village - West Lafayette Location: 2741 N Salisbury St, West Lafayette, Indiana 47906 Phone: (765) 463-7546 | |
Heritage Healthcare Location: 3401 Soldiers Home Rd, West Lafayette, Indiana 47906 Phone: (765) 463-1541 | |
University Place Health Center And Assisted Living Location: 1750 Lindberg Rd, West Lafayette, Indiana 47906 Phone: (765) 464-5600 | |
Cumberland Pointe Health Campus Location: 1051 Cumberland Ave, West Lafayette, Indiana 47906 Phone: (765) 463-2571 | |